JAMA Network Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-01-12 ms2000001940794955 来自台湾省

审稿速度:2.0
经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。
12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。

151 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-11-07 ms7000001954123701 来自广东省

审稿速度:1.0
偏重的研究方向：公共卫生
经验分享：3天UR，不知道后面

23 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-04-25 BRQ123 来自上海

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：医学综合
经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。

114 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-05-19 doctor0805 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;开放获取
经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！

148 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-05-12 ms5000001659052536 来自密苏里

审稿速度:3.0
经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队

142 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-09-17 小鸠摩智来自宁夏

投稿命中率:25.0
偏重的研究方向：骨科
经验分享：2023-09-14 submission pending
2023-09-15 in quality control
2023-09-15 under review
目前就是不知道是否送审了

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-02-10 gaohar17 来自广东省

我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。
投稿三天被拒稿！也算很高效了。
2023/02/06 Submission pending
2023/02/07 In Quality Control
2023/02/08 Under Review
2023/02/09 Review Complete - Decision Processed reject

176 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2022-12-05 ms2000001233459704 来自江苏省

为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗

215 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2021-12-01 1258a929m78暂无昵称

投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？

1154 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110013, encodeId=31d92110013dc, content=审稿速度:2.0 经验分享：09-23-2022投稿，11-22-2022给了大修，时间3周。 12-07-2022修回之后 In Quality Control，12-08-2022 Under Review，12-13-2022 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e45685438, createdName=ms2000001940794955, createdTime=Thu Jan 12 22:44:16 CST 2023, time=2023-01-12, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2167187, encodeId=0377216e187ad, content=审稿速度:1.0 偏重的研究方向：公共卫生 经验分享：3天UR，不知道后面, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbe9046872, createdName=ms7000001954123701, createdTime=Tue Nov 07 10:43:36 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2132736, encodeId=0c562132e363a, content=审稿速度:3.0 经验分享：儿童神经影像方向投稿 2/14/2023 JAMA Pediatrics转 2/16/2023 Under Review 4/21/2023 Review Complete - 小修一审64天有点长，官网写的中位数是45天，期间催了两次，第一次催刚好审稿意见回到编辑这里，到第二次催编辑花了一个多星期出结果。整体审稿人非常友好。编辑给三个星期修改。 5/8/2023 In Quality Control修回 5/11/2023 Accept 整体感觉期刊对格式和统计学要求非常高，修回的时候要求按照期刊格式指南一条一条校队, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc248621971, createdName=ms5000001659052536, createdTime=Fri May 12 14:04:11 CST 2023, time=2023-05-12, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2158179, encodeId=835021581e9ce, content=投稿命中率:25.0 偏重的研究方向：骨科 经验分享：2023-09-14 submission pending 2023-09-15 in quality control 2023-09-15 under review 目前就是不知道是否送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/15/317d4c4242e0b44eb27d4e3bffef35f0.jpg, createdBy=0c702285171, createdName=小鸠摩智, createdTime=Sun Sep 17 19:39:06 CST 2023, time=2023-09-17, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2113917, encodeId=ca0f211391ec8, content=我的我的经验：投稿成功后，邮件只会发到通讯作者邮箱。 投稿三天被拒稿！也算很高效了。 2023/02/06 Submission pending 2023/02/07 In Quality Control 2023/02/08 Under Review 2023/02/09 Review Complete - Decision Processed reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaohar17, createdTime=Fri Feb 10 09:25:22 CST 2023, time=2023-02-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2104378, encodeId=be4b21043e8a4, content=为什么一直是in quality control啊，四天了都，这个的意思是文章还是在编辑手上吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43935422568, createdName=ms2000001233459704, createdTime=Mon Dec 05 11:55:29 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1075817, encodeId=c19c10e5817f4, content=投的JAMA surgery 后，第四天被转投到这里了，请问怎样查看稿件状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvTPxnSVp60tqUs8LABicWcdEWsZ6h1vtddvdt0dLib6rRicC6MMGOw34VotAaA9l0CbJlR2ODMmr3g/132, createdBy=a48a2573379, createdName=1258a929m78暂无昵称, createdTime=Wed Dec 01 11:21:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150005, encodeId=cdc021500054b, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1138105792, createdName=ms2000001164873423, createdTime=Wed Jul 26 22:01:10 CST 2023, time=2023-07-26, status=1, ipAttribution=上海)]

2023-07-26 ms2000001164873423 来自上海

11

114 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务